My understanding is that they did test a subset of participants, but that the 62% figure doesn't figure in the asymptomatic cases. They've made it very confusin

My understanding is that they did test a subset of participants, but that the 62% figure doesn't figure in the asymptomatic cases. They've made it very confusing though, much like how they've explained the half-full dose results.